i3S Diagnostics
Welcome to the i3S Diagnostics website
Perform your test quickly, efficiently, and safely with i3S Diagnostics.
In the past few years, i3S has been at the forefront of research and innovation in health sciences, having focused on diversified topics to perceive key hallmarks of the disease. i3S is committed to advancing healthcare, and translates the know-how produced in-house into tools for new knowledge-based therapies, such as diagnostic tests.
In March 2020, the first patient diagnosed with COVID-19 in Portugal prompted a nationwide response to fight this pandemic by gathering its scientific community to carry out SARS-CoV-2 infection diagnostics. After stepping in into the national task force with the establishment of the COVID-19 laboratory, we gathered a multidisciplinary team dedicated to expanding on our existing service and developing the i3S Diagnostics laboratory.
At i3S Diagnostics, we performed routine coronavirus RT-qPCR-based testing (the gold standard for SARS-CoV-2 diagnosis) for patient care in a competitive time frame, with the capacity for approximately 500 tests per day. i3S COVID-19 laboratory tests hold certification by the National Institute of Health Dr. Ricardo Jorge (INSA) and are listed on the Portugal government's general testing providers' list. Our COVID-19 professional antigen tests are made in Portugal and have INFARMED and CE certification, as well as approval by the European Union.
The ending of the acute phase of the pandemic prompted the implementation of innovative technologies in the field of infectious diseases. Currently, we are establishing partnerships with hospitals from the North region interested in innovative diagnostic tests for microbial and antimicrobial resistance identification and epidemiological surveillance, for better monitoring of their transmission.
Additionally, we offer other services for the external community, such as:
- automated methods for the extraction of nucleic acids with high quality, from a wide range of biological and environmental samples. The purified DNA/RNA can be used in a variety of downstream applications such as Sanger sequencing, Next generation sequencing (NGS), digital PCR, RT-PCR, among others;
- NGS sequencing of microbial genomic DNA or circulating cell-free DNA (cfDNA) for rapid identification of the microorganisms causative of infections;
- testing of antimicrobial activity of innovative materials (e.g. textile surfaces);
- diagnostic and advisory services to a diverse range of sectors (e.g. healthcare, textile industry, corporate events).
At i3S Diagnostics we value a close relationship with our customers, working towards the most personalized and advantageous solution.
Please contact us if we can provide additional information.
Platform Head
Team
Services
- Automated methods for the extraction of nucleic acids;
- Innovative diagnostic tests for microbial and antimicrobial resistance identification;
- NGS sequencing of microbial genomic DNA or circulating cell-free DNA (cfDNA) for rapid identification of the microorganisms causative of infections;
- Antimicrobial activity of innovative materials (e.g. textile surfaces);
- Diagnostic and advisory services to a diverse range of sectors (e.g. healthcare, textile industry, corporate events);
- COVID-19 diagnostics
- SARS-CoV-2 detection service based in RT-qPCR technique, using nasopharyngeal swab or saliva specimens;
- COVID-19 professional antigen tests with INFARMED and CE certification, as well as approval by the European Union.
Please contact us if you have any questions: i3sdiagnostics@i3s.up.pt
Resources
The use of i3S Diagnostics equipment is associated with fees and may require user-supplied materials. More information is available upon request.
- Biomek 4000 (Beckman Coulter) for high-throughput sample analyses
Increase the efficiency of your workflow, and reach high reproducibility levels with this liquid automation workstation coupled to a customizable 12-deck position, including gripper and single- and multi-channel pipetting tools compatible with 96, 384 and 1536 wells. Paired with intuitive, programmable software.
Partnerships
Since the beginning of the SARS-CoV-2 Pandemic, i3S Diagnostics has an established partnership with public health services – ARS-Norte. Furthermore, we have also begun successful corporate partnerships, following a B2B model.
The project DeepFastCoV – “Assessing SARS-CoV-2 co-infections, seasonality and infectiveness along the COVID-19 pandemic while implementing faster diagnosis” – with the reference SAICTCOVID/72535/2020, was co-financed by Operational Program for Competitiveness and Internationalization (COMPETE) and Northern Portugal Regional Operational Programme (NORTE2020) under the PORTUGAL 2020 Partnership Agreement, through the European Structural and Investment Funds.